rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2005-7-21
|
pubmed:abstractText |
Antibodies recognizing a cyclic citrullinated peptide (anti-CCP) are highly specific for rheumatoid arthritis (RA) but their role in psoriatic arthritis (PsA) remains unclear. The aim of this study was therefore to investigate the prevalence of anti-CCP antibodies in PsA and assess their clinical and genetic associations.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1462-0324
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1056-60
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15901902-Adult,
pubmed-meshheading:15901902-Aged,
pubmed-meshheading:15901902-Aged, 80 and over,
pubmed-meshheading:15901902-Arthritis, Psoriatic,
pubmed-meshheading:15901902-Arthritis, Rheumatoid,
pubmed-meshheading:15901902-Autoantibodies,
pubmed-meshheading:15901902-Biological Markers,
pubmed-meshheading:15901902-Female,
pubmed-meshheading:15901902-HLA-DR Antigens,
pubmed-meshheading:15901902-HLA-DRB1 Chains,
pubmed-meshheading:15901902-Humans,
pubmed-meshheading:15901902-Male,
pubmed-meshheading:15901902-Middle Aged,
pubmed-meshheading:15901902-Peptides, Cyclic,
pubmed-meshheading:15901902-Prospective Studies,
pubmed-meshheading:15901902-Rheumatoid Factor,
pubmed-meshheading:15901902-Severity of Illness Index
|
pubmed:year |
2005
|
pubmed:articleTitle |
The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis.
|
pubmed:affiliation |
Royal National Hospital for Rheumatic Diseases, Upper Borough Walls, Bath BA1 1RL, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|